-
Product Insights
NewHepatitis C – Drugs In Development, 2024
Empower your strategies with our Hepatitis C – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis C is a contagious viral infection affecting the liver. It spreads on contact with infected blood. It may be a mild condition or may be chronic, leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea, and vomiting. The predisposing factors of hepatitis C include dialysis, organ transplant, and blood transfusion. The offspring of...
-
Product Insights
NewGastroesophageal (GE) Junction Carcinomas – Drugs In Development, 2024
Empower your strategies with our Gastroesophageal (GE) Junction Carcinomas – Drugs In Development, 2024 report and make more profitable business decisions. Gastroesophageal (GE) junction carcinomas are malignancies occurring at the point where the esophagus meets the stomach. Typically classified as adenocarcinomas or squamous cell carcinomas, adenocarcinomas are more prevalent. Risk factors include chronic gastroesophageal reflux disease (GERD), obesity, and smoking. Symptoms often manifest in advanced stages, including difficulty swallowing, weight loss, and abdominal pain. Diagnosis involves endoscopic procedures and imaging studies....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRK-950 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRK-950 in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TRK-950 in Melanoma Drug Details: TRK-950 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRK-950 in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRK-950 in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TRK-950 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: TRK-950 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – WTX-330 in Non-Hodgkin Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. WTX-330 in Non-Hodgkin Lymphoma Drug Details: WTX-330 is under development for the treatment of relapsed...
-
Analyst Opinions
Digging Deeper into Sustainability – Key Disruptive Forces in Mining (Vol.3)
Disruptive Forces in Mining Report Overview The demand for cleaner and more sustainable energy solutions such as flow batteries is rising owing to growing ESG pressure. Flow batteries have emerged as a promising technology that can contribute to a more reliable and environmentally friendly energy landscape. Leading players as well as startups are investing in developing sustainable solutions. For instance, the new kind of sodium batteries, being developed by startups such as Finland-based Broadbit and India-based AR4 Tech offer much...
-
Product Insights
Mitsui Tahara Solar PV Park
Mitsui Tahara Solar PV Park is a solar PV project located in Aichi, Japan. The project is owned by C-Tech Corp; Mitsui & Co Ltd; Mitsui Chemicals Inc; Mitsui E&S Co Ltd; Toray Industries Inc; Toshiba Energy Systems and Solutions Corp. The project came online in 2014. Empower your strategies with our Mitsui Tahara Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CYB-003 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CYB-003 in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CYB-003 in Major Depressive Disorder Drug Details: CYB-003 is under...